<?xml version="1.0"?><?xml-stylesheet type="text/xsl" href="../../web/xslt/drug-table.xslt"?><drug name = "carmustine inj VIAL>
<dose><value>300</value>
<value>150</value>
</dose><route><value>IV</value>
</route><form><value>inj VIAL</value>
</form><drugname><value>carmustine inj VIAL</value>
</drugname><strength><value>100 mg</value>
</strength><frequency><value>ONCE</value>
</frequency><instruction><value>Administer dose over 3 hours, diluted in 500 mL D5W.</value>
<value>Administer dose over 1 to 2 hours, diluted in 500 mL 0.9% sodium chloride.</value>
</instruction><volume><value></value>
</volume><units><value>mg/m2</value>
</units><additionalnotes><value>Lymphoma. Use ideal BSA if less than actual BSA for dose calculation. Lifetime dose limit: 1400 mg/m2 (risk of pulmonary toxicity).</value>
<value>Metastatic Melanoma. Lifetime dose limit: 1400 mg/m2 (risk of pulmonary toxicity).</value>
</additionalnotes><population><value>ADULT</value>
</population><indicationprn><value></value>
</indicationprn><backgroundinformation><value>http://intraweb01.albertahealthservices.ca/Pharmacy/AHS_FORMULARY/search_details.aspx?id=3353</value>
</backgroundinformation><prninformation><value></value>
</prninformation><ahsformularystatus><value>Formulary with Restrictions.</value>
</ahsformularystatus><ahfsname><value>Antineoplastic Agents</value>
</ahfsname><highalert><value>YES</value>
</highalert><maximumprndose><value>YES</value>
</maximumprndose></drug>